30,50 €
33,89 €
-10% with code: EXTRA
The Biotech Investor
The Biotech Investor
30,50
33,89 €
  • We will send in 10–14 business days.
Tom Abate's reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner. --Thom Calandra, editor in chief, CBS MarketWatch In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. Abate provides guidelines for assessing company leadership, easy-t…
  • SAVE -10% with code: EXTRA

The Biotech Investor (e-book) (used book) | Tom Abate | bookbook.eu

Reviews

(3.63 Goodreads rating)

Description

Tom Abate's reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner. --Thom Calandra, editor in chief, CBS MarketWatch

In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry.
Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for
- tracking the effect of breaking news and the NASDAQ
- anticipating drug trial announcements and FDA approvals
- assessing the potential market, patent rights, and distribution deals for a drug
He looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.

EXTRA 10 % discount with code: EXTRA

30,50
33,89 €
We will send in 10–14 business days.

The promotion ends in 17d.19:20:39

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 0,34 Book Euros!?

Tom Abate's reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner. --Thom Calandra, editor in chief, CBS MarketWatch

In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry.
Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for
- tracking the effect of breaking news and the NASDAQ
- anticipating drug trial announcements and FDA approvals
- assessing the potential market, patent rights, and distribution deals for a drug
He looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)